Search alternatives:
changes decrease » largest decrease (Expand Search), change increases (Expand Search)
larger decrease » marked decrease (Expand Search)
changes decrease » largest decrease (Expand Search), change increases (Expand Search)
larger decrease » marked decrease (Expand Search)
-
261
Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
262
Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
263
Spatio-temporal changes in SDG under multi-scenario spatio-temporal scenarios.
Published 2025Subjects: -
264
Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>.
Published 2024“…As CWP progressed, the CC and CA genotypes of <i>ERCC1</i> rs3212986 decreased and increased significantly, respectively. …”
-
265
Seven forecast scenarios.
Published 2025“…We estimate error correction models, which we ensure are free from residual autocorrelation and structural breaks. We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”
-
266
Forecast for each scenario, 2023-2032.
Published 2025“…We estimate error correction models, which we ensure are free from residual autocorrelation and structural breaks. We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”
-
267
-
268
-
269
-
270
-
271
-
272
-
273
-
274
-
275
-
276
Data.
Published 2025“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
-
277
-
278
Baseline characteristics of patients.
Published 2025“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
-
279
-
280